Security key
126638105
CVRx, Inc. - Common Stock, $0.01 par value (CVRX)
CUSIP: 126638105
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 11,758,612
- Total 13F value
- $194,426,346
- Share change
- +330,890
- SEC-reported price per share
- $16.54
- Number of holders
- 49
- Value change
- -$15,245,912
- Number of buys
- 32
- Number of sells
- 38
- Shares outstanding
- 26,135,461
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
49
Top holders
10
CVRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2021
Previous quarter: Q2 2021
CVRx, Inc. SEC filings
CVRx, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 126638105
Recent filing periods:
Ownership snapshot
Top reported holders of CVRX - CVRx, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Johnson & Johnson Innovat...
Disclosed value leader
Johnson & Johnson Innovat...
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
Johnson & Johnson Innovation - JJDC, Inc. leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Johnson & Johnson Innovation - JJDC, Inc.'s linked filing trail.
Comparable ownership
Top 5
Johnson & Johnson Innovation - JJ...
13%
NEA Management Company, LLC
9.1%
GILDER GAGNON HOWE & CO LLC
2.9%
Venrock Adviser, LLC
2.4%
PRICE T ROWE ASSOCIATES INC /MD/
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. |
13F
Company
|
13%
|
$97,876,000
3,495,575 shares
|
— | 30 Jun 2021 |
| NEA Management Company, LLC |
13F
Company
|
9.1%
|
$66,384,000
2,370,858 shares
|
— | 30 Jun 2021 |
| GILDER GAGNON HOWE & CO LLC |
13F
Company
|
2.9%
|
$21,277,000
759,902 shares
|
— | 30 Jun 2021 |
| Venrock Adviser, LLC |
13F
Company
|
2.4%
|
$17,734,000
633,370 shares
|
— | 30 Jun 2021 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
2.3%
|
$16,800,000
600,000 shares
|
— | 30 Jun 2021 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
1.7%
|
$12,320,000
440,000 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
49
Shares
11,758,612
Rows available
49
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
59
Q3 2021 holders
49
Holder diff
-10
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend